Salvarani Carlo

Dr. Salvarani Carlo


Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2013 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
I(International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD)
International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD)
FDF. Davatchi
F. Davatchi
SAS. Assaad‐Khalil
S. Assaad‐Khalil
KCK.T. Calamia
K.T. Calamia
JCJ.E. Crook
J.E. Crook
NZN. Ziaei
N. Ziaei

25 July 2002 in New England Journal of Medicine
Verified
Journal Article
Closed access
SCSalvarani Carlo
Salvarani Carlo
FCFabrizio Cantini
Fabrizio Cantini
LBLuigi Boiardi
Luigi Boiardi
GHGene G. Hunder
Gene G. Hunder
Polymyalgia rheumatica is an inflammatory disorder manifested principally by stiffness of the neck, shoulder girdle, and pelvic girdle; giant-cell (or temporal) arteritis affects the cranial branches of arteries arising from the aortic arch. The two conditions are believed to be linked and may occur together. Giant-cell arteritis is a serious disorder that can cause blindness as a result of ischemia of the optic nerve or retina. Both disorders respond to corticosteroid therapy. This comprehensive article reviews the clinical manifestations, pathophysiology, and treatment of these disorders.

1 March 2009 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
CMC Mukhtyar
C Mukhtyar
LGL Guillevin
L Guillevin
MCM C Cid
M C Cid
BDB Dasgupta
B Dasgupta
KGK de Groot
K de Groot
RLR Luqmani
R Luqmani

1 July 2008 in The Lancet
Verified
Journal Article
Closed access
SCSalvarani Carlo
Salvarani Carlo
FCFabrizio Cantini
Fabrizio Cantini
GHGene G Hunder
Gene G Hunder

1 January 2006 in The Lancet
Verified
Journal Article
Closed access
AVAugusto Vaglio
Augusto Vaglio
SCSalvarani Carlo
Salvarani Carlo
CBCarlo Buzio
Carlo Buzio

1 January 2021 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
SCSalvarani Carlo
Salvarani Carlo
GDGiovanni Dolci
Giovanni Dolci
MMMarco Massari
Marco Massari
DMDomenico Franco Merlo
Domenico Franco Merlo
SCSilvio Cavuto
Silvio Cavuto
RGRCT-TCZ-COVID-19 Study Group
RCT-TCZ-COVID-19 Study Group
Presentations of coronavirus disease 2019 (COVID-19) range from asymptomatic to severe pneumonia with respiratory failure that can lead to invasive mechanical ventilation and/or death.1,2 In patients with COVID-19 and severe lung disease, hyperinflammation is frequently observed, with an increased plasma concentrations of various proinflammatory cytokines, including interleukin (IL)-6, and acute phase reactants.3-5 This exaggerated inflammatory response caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents one of the most important negative prognostic factors in these patients.6